Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
TIAM1 acts as an actin organization regulator to control adipose tissue–derived pericyte cell fate
Ginny Ching-Yun Hsu, Yiyun Wang, Amy Z. Lu, Mario A. Gomez-Salazar, Jiajia Xu, Dongqing Li, Carolyn Meyers, Stefano Negri, Sintawat Wangsiricharoen, Kristen Broderick, Bruno Peault, Carol Morris, Aaron W. James
Ginny Ching-Yun Hsu, Yiyun Wang, Amy Z. Lu, Mario A. Gomez-Salazar, Jiajia Xu, Dongqing Li, Carolyn Meyers, Stefano Negri, Sintawat Wangsiricharoen, Kristen Broderick, Bruno Peault, Carol Morris, Aaron W. James
View: Text | PDF
Research Article Bone biology Cell biology

TIAM1 acts as an actin organization regulator to control adipose tissue–derived pericyte cell fate

  • Text
  • PDF
Abstract

Pericytes are multipotent mesenchymal precursor cells that demonstrate tissue-specific properties. In this study, by comparing human adipose tissue– and periosteum-derived pericyte microarrays, we identified T cell lymphoma invasion and metastasis 1 (TIAM1) as a key regulator of cell morphology and differentiation decisions. TIAM1 represented a tissue-specific determinant between predispositions for adipocytic versus osteoblastic differentiation in human adipose tissue–derived pericytes. TIAM1 overexpression promoted an adipogenic phenotype, whereas its downregulation amplified osteogenic differentiation. These results were replicated in vivo, in which TIAM1 misexpression altered bone or adipose tissue generation in an intramuscular xenograft animal model. Changes in pericyte differentiation potential induced by TIAM1 misexpression correlated with actin organization and altered cytoskeletal morphology. Small molecule inhibitors of either small GTPase Rac1 or RhoA/ROCK signaling reversed TIAM1-induced morphology and differentiation in pericytes. In summary, our results demonstrate that TIAM1 regulates the cellular morphology and differentiation potential of human pericytes, representing a molecular switch between osteogenic and adipogenic cell fates.

Authors

Ginny Ching-Yun Hsu, Yiyun Wang, Amy Z. Lu, Mario A. Gomez-Salazar, Jiajia Xu, Dongqing Li, Carolyn Meyers, Stefano Negri, Sintawat Wangsiricharoen, Kristen Broderick, Bruno Peault, Carol Morris, Aaron W. James

×

Figure 4

TIAM1 misexpression alters pericyte cellular morphology and gene targets of Rac1 and RhoA/ROCK signaling.

Options: View larger image (or click on image) Download as PowerPoint

TIAM1 misexpression alters pericyte cellular morphology and gene target...
(A) Cellular morphology of human pericytes 48 hours after treatment with TIAM1 siRNA or scramble siRNA. F-actin staining appears green, while TIAM1 immunostaining appears red. (B) Quantification of F-actin cell length and cell width among TIAM1 siRNA– or scramble siRNA–treated human pericytes. Each dot represents an individual cell, with images obtained from 3 random high-magnification fields from each group. (C) Specific target gene expression for Rac1 (ARPC2) and RhoA/ROCK (SRF) signaling pathways among TIAM1 siRNA– or scramble siRNA–treated human pericytes, 24 hours after treatment by qRT-PCR. ARPC2, actin related protein 2/3 complex subunit 2; SRF, serum response factor. (D) Cellular morphology of human pericytes 48 hours after incubation with TIAM1 or control plasmids. F-actin staining appears green, while TIAM1 immunostaining appears red. (E) Quantification of F-actin angulation, cell length, and cell width among human pericytes treated with TIAM1 or control plasmid. Each dot represents an individual cell, with images obtained from 3 random high-magnification fields from each group. (F) Specific target gene expression for Rac1 (ARPC2) and RhoA/ROCK (SRF) pathways, by qRT-PCR, 48 hours after treatment. *P < 0.05; **P < 0.01. Statistical analysis was performed using a 2-sample Student’s t test. White scale bars: 20 μm.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts